Silodosin Capsule
Product Images NDC 42291-778

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Silodosin (NDC 42291-778). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Avkare, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

30 (777 30)

This describes a medication known as Silodosin Capsules, which is only available with a prescription. The usual recommended dosage is one capsule per day, taken with a meal. Each capsule contains 4mg of Sibdosi. It is important to refer to the package insert for full prescribing information. The medication needs to be stored between 20-25°C and should be protected from light and moisture. It is manufactured for ARAFE, Puksk, TH 38478 by Al Pharmaceuticasof Y LLG in Brokhaven, Y 11710. The package contains 30 capsules, and the expiration date is April 2022.*

FDA Label Image

90 (778 90)

This text describes a prescription drug called Silodosin, which is in the form of capsules with NDC 42291-778-00. Each capsule contains 8mg of Silodosin. The recommended dose is one capsule per day, taken with a meal. The package contains full prescribing information. The drug should be stored at temperatures between 15-30°C and protected from moisture and light. It is manufactured for AKARE and manufactured by Amneal Pharmaceuticals LLC, located in Brookhaven, New York. The expiration date is April 2022.*

FDA Label Image

Structure (Silodosin Capsules 1)

FDA Label Image

As (Silodosin Capsules 2)

FDA Label Image

Fg (Silodosin Capsules 3)

FDA Label Image

Jh (Silodosin Capsules 4)

FDA Label Image

Ad (Silodosin Capsules 5)

FDA Label Image

Uy (Silodosin Capsules 6)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.